PL2173710T3 - Nowa postać krystaliczna - Google Patents

Nowa postać krystaliczna

Info

Publication number: PL2173710T3
Authority: PL; Poland
Prior art keywords: crystalline form; novel crystalline; novel; crystalline
Prior art date: 2007-08-10

Application number

PL08788654T

Other languages

English (en)

Inventor

Axel Becker

Original Assignee

Generics Uk Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-08-10

Filing date

2008-08-08

Publication date

2016-02-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38543380&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2173710(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-08-08 Application filed by Generics Uk Ltd filed Critical Generics Uk Ltd

2016-02-29 Publication of PL2173710T3 publication Critical patent/PL2173710T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyrrole Compounds (AREA)
Medicinal Preparation (AREA)
Liquid Crystal Substances (AREA)
Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

PL08788654T 2007-08-10 2008-08-08 Nowa postać krystaliczna PL2173710T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB0715626.8A GB0715626D0 (en)	2007-08-10	2007-08-10	Crystalline form of zofenopril calcium
PCT/GB2008/050683 WO2009022168A1 (en)	2007-08-10	2008-08-08	Novel crystalline form
EP08788654.5A EP2173710B1 (en)	2007-08-10	2008-08-08	Novel crystalline form

Publications (1)

Publication Number	Publication Date
PL2173710T3 true PL2173710T3 (pl)	2016-02-29

Family

ID=38543380

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL08788654T PL2173710T3 (pl)	2007-08-10	2008-08-08	Nowa postać krystaliczna

Country Status (14)

Country	Link
US (1)	US8710241B2 (pl)
EP (1)	EP2173710B1 (pl)
JP (1)	JP5455905B2 (pl)
CN (1)	CN101815702B (pl)
AU (1)	AU2008288295B2 (pl)
CA (1)	CA2694835C (pl)
DK (1)	DK2173710T3 (pl)
ES (1)	ES2556227T3 (pl)
GB (1)	GB0715626D0 (pl)
HR (1)	HRP20151166T1 (pl)
HU (1)	HUE028205T2 (pl)
PL (1)	PL2173710T3 (pl)
PT (1)	PT2173710E (pl)
WO (1)	WO2009022168A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8853421B2 (en)	2008-02-27	2014-10-07	Generics [Uk] Limited	Crystalline forms of zofenopril calcium
US20110118328A1 (en) *	2008-02-27	2011-05-19	Vinayak Gore	Novel crystalline forms
SI23949A (sl)	2011-12-19	2013-06-28	Silverstone Pharma	Nove kristalne soli zofenoprila, postopek za njihovo dobivanje in njihova uporaba v terapiji
CN104138359B (zh) *	2013-05-06	2016-03-02	扬子江药业集团上海海尼药业有限公司	佐芬普利钙片的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1144930A (en) *	1978-08-11	1983-04-19	Miguel A. Ondetti	Mercaptoacyl derivatives of substituted prolines
US4316906A (en)	1978-08-11	1982-02-23	E. R. Squibb & Sons, Inc.	Mercaptoacyl derivatives of substituted prolines
IT1301993B1 (it) *	1998-08-04	2000-07-20	Menarini Ricerche Spa	Processo per la preparazione di zofenopril sale di calcio.
WO2005070463A2 (en)	2004-01-12	2005-08-04	Sepracor, Inc.	Compositions comprising (s)-amlodipine malate and an angiotensin receptor blocker and methods of their use
PT1899297E (pt) *	2005-07-01	2016-03-21	Generics Uk Ltd	Zofenopril de cálcio em forma polimórfica c
EP2041083B1 (en)	2006-05-26	2014-11-05	Generics [UK] Limited	Methods of preparing zofenopril calcium
CN101012192A (zh) *	2007-01-30	2007-08-08	广东邦民制药厂有限公司	一种佐芬普利钙的制备方法

2007
- 2007-08-10 GB GBGB0715626.8A patent/GB0715626D0/en not_active Ceased
2008
- 2008-08-08 CN CN2008801101074A patent/CN101815702B/zh not_active Expired - Fee Related
- 2008-08-08 DK DK08788654.5T patent/DK2173710T3/en active
- 2008-08-08 US US12/671,328 patent/US8710241B2/en not_active Expired - Fee Related
- 2008-08-08 HR HRP20151166TT patent/HRP20151166T1/hr unknown
- 2008-08-08 EP EP08788654.5A patent/EP2173710B1/en not_active Not-in-force
- 2008-08-08 CA CA2694835A patent/CA2694835C/en not_active Expired - Fee Related
- 2008-08-08 ES ES08788654.5T patent/ES2556227T3/es active Active
- 2008-08-08 JP JP2010519529A patent/JP5455905B2/ja not_active Expired - Fee Related
- 2008-08-08 HU HUE08788654A patent/HUE028205T2/en unknown
- 2008-08-08 PT PT87886545T patent/PT2173710E/pt unknown
- 2008-08-08 WO PCT/GB2008/050683 patent/WO2009022168A1/en not_active Ceased
- 2008-08-08 PL PL08788654T patent/PL2173710T3/pl unknown
- 2008-08-08 AU AU2008288295A patent/AU2008288295B2/en not_active Ceased

Also Published As

Publication number	Publication date
HUE028205T2 (en)	2016-12-28
AU2008288295B2 (en)	2013-06-06
US8710241B2 (en)	2014-04-29
GB0715626D0 (en)	2007-09-19
EP2173710A1 (en)	2010-04-14
JP2010535753A (ja)	2010-11-25
ES2556227T3 (es)	2016-01-14
CN101815702A (zh)	2010-08-25
EP2173710B1 (en)	2015-09-16
WO2009022168A1 (en)	2009-02-19
CN101815702B (zh)	2012-10-24
JP5455905B2 (ja)	2014-03-26
CA2694835C (en)	2013-01-29
AU2008288295A1 (en)	2009-02-19
US20110098334A1 (en)	2011-04-28
PT2173710E (pt)	2016-01-12
HRP20151166T1 (hr)	2016-01-01
DK2173710T3 (en)	2015-11-23
CA2694835A1 (en)	2009-02-19

Publication	Publication Date	Title
GB0819182D0 (en)	2008-11-26	Crystalline forms
EP2146745A4 (en)	2011-11-30	NOVEL CONNECTIONS
EP2152081A4 (en)	2010-10-06	NEW CONNECTIONS
GB0705882D0 (en)	2007-05-02	Novel compounds
GB0706630D0 (en)	2007-05-16	Novel compounds
GB0705803D0 (en)	2007-05-02	Novel compounds
PL2173710T3 (pl)	2016-02-29	Nowa postać krystaliczna
ZA200806859B (en)	2009-08-26	Novel crystalline compounds
GB0706772D0 (en)	2007-05-16	Novel compound
GB0703973D0 (en)	2007-04-11	Novel compounds
IL195092A0 (en)	2009-11-18	Crystalline form of (s)-1-phenylethylammonium (r)-diphenyl-methanesulphinyl-acetate
HU0800755D0 (en)	2009-03-30	Novel crystalline forms
GB0817164D0 (en)	2008-10-29	Crystalline forms
IL213288A0 (en)	2011-07-31	Crystalline forms
GB0717333D0 (en)	2007-10-17	Novel compound
GB0717338D0 (en)	2007-10-17	Novel compound
GB0717468D0 (en)	2007-10-17	Novel compound
GB0720917D0 (en)	2007-12-05	Novel compound
GB0717336D0 (en)	2007-10-17	Novel compound
GB0717335D0 (en)	2007-10-17	Novel compound
GB0717334D0 (en)	2007-10-17	Novel compound
GB0717332D0 (en)	2007-10-17	Novel compound
GB0710864D0 (en)	2007-07-18	Novel compound
GB0700992D0 (en)	2007-02-28	Novel compounds
GB0704088D0 (en)	2007-04-11	Novel compounds